BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2720708)

  • 1. Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes.
    Blomgren H
    Cancer Immunol Immunother; 1989; 29(2):151-3. PubMed ID: 2720708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cyclophosphamide derivatives on cellular cytotoxicity (NK, ADCC) in vitro.
    Wasik M; Rychlik G; Górski A
    Arch Immunol Ther Exp (Warsz); 1990; 38(3-4):259-65. PubMed ID: 2102658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
    Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
    Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mafosfamide enhances interleukin-2-generated human effector cell cytotoxic activity against K562 myeloid leukaemia cells.
    Hassan HT
    Med Oncol; 1994; 11(3-4):135-6. PubMed ID: 7633833
    [No Abstract]   [Full Text] [Related]  

  • 5. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
    Mandler RN; Biddison WE; Mandler R; Serrate SA
    J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
    Botzler C; Kis K; Issels R; Multhoff G
    Exp Hematol; 1997 Apr; 25(4):338-44. PubMed ID: 9131009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes.
    Ortaldo JR; Mantovani A; Hobbs D; Rubinstein M; Pestka S; Herberman RB
    Int J Cancer; 1983 Mar; 31(3):285-9. PubMed ID: 6826252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
    Uchida A; Klein E
    Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ASTA-Z 7557 impairs human natural killer (NK) cell activity.
    Condiotti R; Slavin S; Nagler A
    Leuk Res; 1996 Feb; 20(2):169-74. PubMed ID: 8628016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of natural killer cell activity by interferon and interleukin-2 in human large granular lymphocytes inhibited by cyclosporine.
    Ramsey KM; Dyer D; Stocks N; Djeu JY
    Transplant Proc; 1984 Dec; 16(6):1628-31. PubMed ID: 6334388
    [No Abstract]   [Full Text] [Related]  

  • 13. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression.
    Reissmann T; Hilgard P; Voegeli R; Zeller J
    J Cancer Res Clin Oncol; 1989; 115(6):525-30. PubMed ID: 2606928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agar capillary clonogenic microassays for cellular immunocytotoxic activities in human leukaemia and lymphoma.
    Maurer HR; Hassan HT
    Leuk Lymphoma; 1993 Mar; 9(4-5):305-13. PubMed ID: 7688626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice.
    Pica F; Mastino A; Grelli S; Jezzi T; Favalli C
    J Chemother; 1989 Jul; 1(4 Suppl):1167-9. PubMed ID: 16312818
    [No Abstract]   [Full Text] [Related]  

  • 17. Augmentation of human natural killer cell activity by cyclophosphamide in vitro.
    Sharma B; Vaziri ND
    Cancer Res; 1984 Aug; 44(8):3258-61. PubMed ID: 6589041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hydrocortisone on human natural killer activity and its modulation by beta interferon.
    Fuggetta MP; Graziani G; Aquino A; D'Atri S; Bonmassar E
    Int J Immunopharmacol; 1988; 10(6):687-94. PubMed ID: 3198305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increase in NK-activity using superlow doses of the immunomodulator cycloferon].
    Shevchenko EV; Finkel'shteĭn BB; Ivanov VA
    Tsitologiia; 2001; 43(7):698-700. PubMed ID: 11552653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-induced changes in the susceptibility of murine and human lymphoma cells to natural cytotoxic lymphocytes.
    Giuliani-Bonmassar A; Graziani G; Frati L; Bonmassar E
    Int J Tissue React; 1984; 6(1):35-41. PubMed ID: 6585352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.